See the DrugPatentWatch profile for Ivermectin
Ivermectin's supply chain involves various pharmaceutical companies, with manufacturing and distribution playing key roles in its availability [1]. Companies involved range from those producing the active pharmaceutical ingredient (API) to those formulating the final drug product. The complexity of the supply chain can be influenced by global demand, regulatory requirements, and the sourcing of raw materials [1].
Who are the major pharmaceutical companies involved with Ivermectin?
While specific company names directly involved in the current Ivermectin supply chain for all its applications are not comprehensively detailed in public records, several types of pharmaceutical entities are typically engaged. These include API manufacturers, contract manufacturing organizations (CMOs) that produce the finished dosage forms, and distributors that handle logistics [1]. Companies that historically or currently hold patents related to Ivermectin formulations may also be significant players. Examining patent filings can often reveal entities with a vested interest in the drug's production and market [2].
How is Ivermectin manufactured?
The manufacturing of Ivermectin involves chemical synthesis to produce the active pharmaceutical ingredient (API) [1]. This API is then formulated into various dosage forms, such as tablets or topical solutions, by pharmaceutical companies [1]. The process requires adherence to strict quality control standards and regulatory guidelines to ensure the purity and efficacy of the final product.
What is the patent status for Ivermectin?
Ivermectin, as a compound, has been off-patent for many years, meaning its original patents have expired [3]. However, specific formulations, new uses, or manufacturing processes related to Ivermectin may still be subject to patent protection. DrugPatentWatch.com tracks patent information for a wide range of drugs, including Ivermectin, providing details on expired and active patents that could affect its market [2].
How does Ivermectin's supply chain differ for different uses?
The supply chain for Ivermectin can vary depending on its intended use. For human antiparasitic treatments, pharmaceutical-grade Ivermectin is manufactured under stringent regulations [1]. For veterinary applications, different formulations and manufacturing standards may apply, potentially involving separate supply chains and companies specializing in animal health products [1].
Are there supply chain challenges for Ivermectin?
Supply chain challenges for Ivermectin can arise from various factors, including fluctuations in raw material availability, manufacturing capacity, and global demand [1]. During periods of significantly increased demand, such as those experienced recently, supply chain disruptions can become more pronounced, leading to shortages or increased prices [1]. Regulatory hurdles and the complexity of international logistics also contribute to potential challenges.